Enzymotec Nets Australian Patent for Omega-Sterol Ingredient

MIGDAL HAEMEQ, IsraelEnzymotec was granted an Australian patent for its Omega-sterols ingredient, a hybrid of naturally occurring phytosterols and omega-3s. The patent (No. AU-0552025002) is for the use of this ingredient as a functional food for diabetics and is one of five different patents covering various properties, composition and methods of use for this ingredient. According to the company, Omega-sterols was clinically proven to be effective for blood lipid control and for supporting healthy levels of both blood triglycerides and LDL-cholesterol (bad cholesterol) in humans.

Omega sterolsTM were also clinically proven to be better than standard sterol-esters since they do not hinder the absorption of certain vitamins, such as Vitamin E. Additionally, there is an initial indication that Omega-Sterols may reduce CRP levels and blood pressure as-well," said Sigalit Zchut, Ph.D., director of R&D for Enzymotec.

Eyal Afergan, Ph.D., omega-3 category manager for Enzymotec, added:  This product and its patent applications are an essential part of our strategy to lead the market through innovation and to provide a clear edge to our customers."